← All stocks

RxSight, Inc.

RXST Net selling
CIK 0001111485 #3743 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$117.95K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$117.95K
4 of 4 sales
Net
−$117.95K
−$117.95K against sales at will

By person

15 insiders · 8 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Wilterding Mark
Chief Financial Officer
$54.04K (1)
−$54.04K
25,049
0.0602%
$174.34K
Kurtz Ronald M MD
Chief Medical Officer
$35.50K (1)
−$35.50K
836,385
2.01%
$5.82M
+1.0%
Goldshleger Ilya
Chief Operating Officer
$14.21K (1)
−$14.21K
82,881
0.1993%
$576.85K
+90.0%
Weinberg Eric
See remarks
$14.21K (1)
−$14.21K
536,419
1.29%
$3.73M
+73.1%
Corley Jesse Anderson
Director
89,437
0.2150%
$622.48K
+460.3%
Tammenoms Bakker Juliet
Director
85,183
0.2048%
$592.87K
+127.8%
Andrews Julie
Director
78,076
0.1877%
$543.41K
+157.8%
Warner Robert Keith
Director
78,076
0.1877%
$543.41K
+157.8%
PALMISANO ROBERT J
Director
78,076
0.1877%
$543.41K
+157.8%
LINK WILLIAM J PHD
Director
74,892
0.1801%
$521.25K
+176.3%
Fountain Tamara
Director
72,582
0.1745%
$505.17K
+128.3%
COHEN RAYMOND W
Director
66,532
0.1600%
$463.06K
Maniar Shweta
Director
55,172
0.1326%
$384.00K
+275.7%
Thunen Shelley B
See remarks
38,354
0.0922%
$266.94K
+25.5%
Gaines Scott
Chief Customer Officer
14,848
0.0357%
$103.34K
+33.0%
Insider
Date
Role
Action
Shares
Price
Amount
Weinberg Eric
15 Sep 2026
See remarks
Exercised, kept
35,168
$4.34
$152.63K
Weinberg Eric
2 Sep 2026
See remarks
Sell
2,041
$6.96
$14.21K
Goldshleger Ilya
2 Sep 2026
Chief Operating Officer
Sell
2,041
$6.96
$14.21K
Wilterding Mark
2 Sep 2026
Chief Financial Officer
Sell
7,765
$6.96
$54.04K
Kurtz Ronald M MD
2 Sep 2026
Chief Medical Officer
Sell
5,100
$6.96
$35.50K
Goldshleger Ilya
17 Apr 2026
Chief Operating Officer
Exercised, kept
12,489
$4.13
$51.58K
Goldshleger Ilya
25 Sep 2025
See remarks
Exercised, kept
8,349
$4.13
$34.48K
Goldshleger Ilya
25 Sep 2025
See remarks
Exercised, kept
15,096
$4.34
$65.52K

What was left out

Form 4 filings counted 27
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 480,218
History held since 2 Aug 2021